New Bill in New York Seeks to Allow CBD Oil for Pets | CashCropToday
0 Shares 179 Views

New Bill in New York Seeks to Allow CBD Oil for Pets

March 21, 2018
179 Views

A new bill proposed in the New York Assembly, A10104, aims to allow pets with certain medical conditions access to medical grade CBD oil via a licensed veterinarians prescription.

Natural pet supplement sales have nearly doubled between 2008 and 2014, with an increase in sales that have shown the U.S. retail market to be worth $1.6B.

The new bill will provide pets access to hemp derived, high quality, Cannabidiol, or better known to the public as CBD oil. CBD oil has been known as useful in pets treating separation anxiety, epilepsy and other various inflammatory conditions.

Bill A10104 currently rests in the hands of the New York Senate Health Committee for approval.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
188 views
Global
188 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
185 views
Manufacturing
185 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: